CorrectionPublished 12 October 2026Correction: Evaluation of real-time LAMP assay for detection of Entamoeba species in clinical stool samples from a tertiary care center in North IndiaFrontiers Production OfficeFrontiers in Parasitologydoi 10.3389/fpara.2026.2017245
ReviewPublished 12 October 2026Gut microbiota, microbial metabolites, and mucosal barrier dysfunction in benign anorectal disorders and ulcerative colitis: shared mechanisms, clinical links, and precision interventionsHexue Yuan · Maofang Zhao · Yunfen Wang · Chen Shen · Delong Liu · Chunxiao Wang · Jian LiuFrontiers in Medicinedoi 10.3389/fmed.2026.1979206
ReviewPublished 9 October 2026Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicineJing Chen · Jing Du · Baoxi Mu · Jie Zhang · Guangbin Shang · Xiaojun YanFrontiers in Pharmacologydoi 10.3389/fphar.2026.1956353
ReviewPublished 8 October 2026Chinese herbal medicine for ulcerative colitis: product-level clinical evidence, mechanistic appraisal, and a roadmap to precision translationYingxiu Wu · Jianxiong Ren · Huibiao Li · Shiyu Qi · Wei KeFrontiers in Pharmacologydoi 10.3389/fphar.2026.1976448
Original ResearchPublished 7 October 2026Multi-cohort meta-analysis, single-cell and Mendelian randomization analyses with experimental validation identify RHBDF2 as a shared mediator of ulcerative colitis and blood–brain barrier disruptionJiongjiong Cheng · Aman XuFrontiers in Synaptic Neurosciencedoi 10.3389/fnsyn.2026.1970578
Original ResearchPublished 2 October 2026Integrated transcriptome and single-cell RNA sequencing identifies transient receptor potential channel-related biomarkers in ulcerative colitisTiantian Bao · Tianru Xie · Jiang Chen · Yibo Cao · Jian Zhu · Pingliang Sun · Tao YangFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1902447
Original ResearchPublished 1 October 2026Evaluation of real-time LAMP assay for detection of Entamoeba species in clinical stool samples from a tertiary care center in North IndiaDevyani Sharma · Usha Dutta · Divya Rattan · Upninder Kaur · Shinichi Inoue · Shinjiro Hamano · Ruby Jain · Kawaljeet Singh Sandha · Rakesh Sehgal · P. V. M. LakshmiFrontiers in Parasitologydoi 10.3389/fpara.2026.1937802
Brief Research ReportPublished 22 September 2026Irritable bowel syndrome-like symptoms are associated with increased healthcare utilization in patients with inflammatory bowel diseaseSophie Montgomery · Alessandra Saraga · Nathan David Vanshelboym Rothschild · Mostafa A. Soliman · Audrey N. Kim · Isabella Midura · Rishita Tikkala · Lina Zhang · Shana Rakowsky · Loren Rabinowitz · Konstantinos Papamichael · Adam S. Cheifetz · Sarah BallouFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1924176
Systematic ReviewPublished 18 September 2026Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysisMohamad Yousef Alabdallat · Omar Al Ta’ani · Tarek Bakain · Ahmad Al-Dwairy · Mohammad Ghannam · Abdulrahman Atasi · Fares Mashal · Khaled Moghib · Nader Bakheet · Javed G. Jagroo · Rohan Hehr · Ahmed Salem · Derrick CheungFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1937925
Original ResearchPublished 17 September 2026Primary biliary cirrhosis and inflammatory bowel disease: a two-sample bidirectional Mendelian randomization studyMingyi Yang · Jiale Xie · Jing Hu · Pengfei Wen · Lin Liu · Zhi Yang · Ming Zhang · Changliang Zhu · Yani SuExperimental Biology and Medicinedoi 10.3389/ebm.2026.10940
ReviewPublished 4 August 2026Therapeutic drug monitoring with non-anti-TNF advanced therapies in inflammatory bowel disease: current and evolving paradigmsFaris Chater · Thomas D. Butler · Jimmy K. LimdiFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1860608
Brief Research ReportPublished 27 July 2026Optimised mesalazine therapy reduces ulcerative colitis recurrence across the mild-to-moderate disease spectrum: the IMPACT studyBolette Christophersen · John Fullarton · Rachel WestFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1874051
Original ResearchPublished 23 July 2026SR9009 regulates macrophage polarization via the NR1D1/NF-κB axis to ameliorate obesity-associated ulcerative colitisZhixue Zheng · Xuan Cai · Yaqi Liu · Jingtao BiFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1762028
EditorialPublished 22 July 2026Editorial: Advances in the treatment of acute severe ulcerative colitisHirannya Karunadasa · Ronan O’Connor · Danny Con · Ashish Srinivasan · Abhinav VasudevanFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1924886
ReviewPublished 18 May 2026GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunityJoseph J. Lee · Pratikiran Bajgain · Amy L. LightnerFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1790420
Original ResearchPublished 22 April 2026Surgical management of ulcerative colitis-associated colorectal cancer in a 20-year period, a single-centre studyJános Tajti · László Libor · Szabolcs Ábrahám · Zsolt Simonka · Anikó Maráz · Attila Paszt · Tamás Molnár · Judit Oláh · György LázárPathology and Oncology Researchdoi 10.3389/pore.2026.1612362
ReviewPublished 13 April 2026Neuro-regulatory drug discovery (NRGDD): a neural-circuit framework for systemic therapeutic modulationSarfaraz K. NiaziFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1782364
Mini ReviewPublished 8 December 2025Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disordersBiljana Horn · Giovanni Mambrini · Maureen Roden · Caralee Schaefer · Dirk Thye · Mauro MagnaniFrontiers in Drug Deliverydoi 10.3389/fddev.2025.1730142
